Equity research forecasts for Centene Corporation (NYSE: CNC) project a steady valuation path through 2026, with Wall Street median price targets pointing toward moderate upside around $71 per share, while individual algorithmic models project ranges spanning from $55 to higher bull-case figures. These projections are anchored by anticipated managed care revenue expansion, disciplined cost management, and ongoing execution within government healthcare insurance sectors, though regulatory adjustments remain key variables.